UiPath Toekomstige groei

Future criteriumcontroles 1/6

UiPath zal naar verwachting groeien in winst en omzet met respectievelijk 19.3% en 9.7% per jaar. De winst per aandeel zal naar verwachting groeien met 25.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 0.8% zijn.

Belangrijke informatie

19.3%

Groei van de winst

25.9%

Groei van de winst per aandeel

Software winstgroei16.9%
Inkomstengroei9.7%
Toekomstig rendement op eigen vermogen0.8%
Dekking van analisten

Good

Laatst bijgewerkt05 Nov 2024

Recente toekomstige groei-updates

Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 01
Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Recent updates

UiPath: Buy For Strong Recovery Potential, Future Enterprise AI Growth

Oct 28

UiPath: Great Opportunity To Buy This AI Stock At A Cheap Price

Oct 14

UiPath Inc.'s (NYSE:PATH) Share Price Could Signal Some Risk

Oct 04
UiPath Inc.'s (NYSE:PATH) Share Price Could Signal Some Risk

UiPath Inc.: Bullish Support Is Finally Here - Turnaround Likely Prolonged

Sep 14

UiPath Q2 Earnings: On The Path Higher (Rating Upgrade)

Sep 06

Why UiPath Inc. (NYSE:PATH) Could Be Worth Watching

Aug 23
Why UiPath Inc. (NYSE:PATH) Could Be Worth Watching

UiPath: Fighting Headwinds With Strong Fundamentals And AI Optionality

Aug 13

UiPath: Not Your Path To Profits

Aug 05

Calculating The Fair Value Of UiPath Inc. (NYSE:PATH)

Aug 02
Calculating The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: On The Long Road To Recovery

Jul 13

UiPath Crashes On Generative AI Headwinds: Buy The Fear (Ratings Upgrade)

Jun 30

Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 01
Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

The Price Is Right For UiPath Inc. (NYSE:PATH) Even After Diving 37%

May 31
The Price Is Right For UiPath Inc. (NYSE:PATH) Even After Diving 37%

UiPath Earnings: It Would Be A Sin To Compound My Mistake (Rating Downgrade)

May 30

UiPath Q1 Earnings Preview: Enterprise Demand Should Sustain

May 24

UiPath: A Hold Based On Demystifying The AI Hype (Rating Downgrade)

Apr 24

UiPath: Still Unloved

Apr 18

UiPath: Post-Earnings Selloff Is A Gift, Positive GAAP Income, Net Cash (Upgrade)

Mar 20

Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

Feb 28
Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

UiPath: I Am Not Ready To Pay Premium Here

Feb 19

Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

Feb 01
Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

UiPath: Leader In An Unloved Segment

Jan 16

UiPath's Bots Make Generative AI Apps Work Better

Jan 09

UiPath: From IPO Hype To Market Leadership, And Challenges Ahead

Dec 29

A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

Nov 27
A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: Correction Over; Outperformance Ahead

Nov 26

UiPath May Beat Expectations Again, Staying Expensive

Nov 20

UiPath: Left Underappreciated

Oct 16

UiPath: The Real AI Pioneer

Sep 14

UiPath Q2 2024 Earnings Preview: I Expect FY24 Guidance To Be Raised

Sep 05

UiPath: AI Revolution In RPA - Major Growth Potential

Aug 18

Winst- en omzetgroeiprognoses

NYSE:PATH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
1/31/20271,757-1263843798
1/31/20261,579-14235535722
1/31/20251,422-17232433022
7/31/20241,383-112327334N/A
4/30/20241,354-87325332N/A
1/31/20241,308-90292299N/A
10/31/20231,211-151242247N/A
7/31/20231,148-178168178N/A
4/30/20231,103-23894110N/A
1/31/20231,059-328-34-10N/A
10/31/20221,040-364-135-110N/A
7/31/2022998-429-132-108N/A
4/30/2022951-408-109-90N/A
1/31/2022892-526-67-55N/A
10/31/2021810-436-42-31N/A
7/31/2021737-384-52N/A
4/30/2021681-2843036N/A
1/31/2021608-922629N/A
1/31/2020336-520-380-359N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat PATH de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat PATH de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat PATH de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van PATH ( 9.7% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van PATH ( 9.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen PATH zal naar verwachting over 3 jaar laag zijn ( 0.8 %).


Ontdek groeibedrijven